Protocolized screening effectively identifies myocardial recovery following destination therapy left ventricular assist device implantation.

Nathan J SmithNicholas CollarPadmaraj DuvvuriBryan MilesRuizhe WuAniko SzaboNunzio GaglianelloLyle D JoyceDavid L Joyce

Published in: Artificial organs (2022)

Myocardial recovery in DT LVAD patients can be achieved at a higher rate than previously reported. Revascularization at the time of LVAD is safe and may be beneficial. LVAD therapy may not be the final destination in these patients.

Keyphrases

left ventricular assist device
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
left ventricular
peritoneal dialysis
gene expression
patient reported
cell therapy